The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 10,949 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 8,190 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111206 | 5,407 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,830 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| ARQULE INC | COM | 04269E107 | 2,322 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 7,259 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 72,360 | 1,440,000 | SH | SOLE | 1,440,000 | 0 | 0 | ||
| AZURRX BIOPHARMA INC | COM | 05502L105 | 417 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| BIOFRONTERA AG | SPONSORED ADR | 09075G105 | 4,755 | 391,400 | SH | SOLE | 391,400 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 222 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES | COM | 09627Y109 | 22,218 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 5,474 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 6,240 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 25,200 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | COM | 21887L107 | 6,408 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 803 | 161,400 | SH | SOLE | 161,400 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 9,360 | 697,500 | SH | SOLE | 697,500 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 16,527 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 3,726 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 9,865 | 945,000 | SH | SOLE | 945,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 22,536 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| GTX INC | SHS | M46135105 | 3,827 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| LOXO ONCOLOGY | COM | 548862101 | 30,359 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 7,425 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| MIRAGEN THERAPEUTICS INC | COM | 60463E103 | 7,692 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 7,499 | 1,111,000 | SH | SOLE | 1,111,000 | 0 | 0 | ||
| POLARITYTE INC | COM | 731094108 | 18,832 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 1,333 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 6,071 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 7,171 | 505,000 | SH | SOLE | 505,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 10,980 | 1,830,000 | SH | SOLE | 1,830,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 8,218 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICALS INC | COM | 90400D108 | 6,149 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 11,388 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 6,661 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 6,685 | 320,200 | SH | SOLE | 320,200 | 0 | 0 | ||